Quarterly report [Sections 13 or 15(d)]

REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (Details)

v3.25.3
REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (Details) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Increase (Decrease) in Stockholders' Equity        
Beginning balance (in shares)     6,962  
Beginning balance $ (114,386) $ (140,329) $ (164,366) $ (121,498)
Net loss (46,456) (12,150) (63,662) (32,048)
Foreign currency translation adjustments, net (62) 659 660 801
Stock-based compensation $ 324 716 $ (205) 1,641
Ending balance (in shares) 13,333   13,333  
Ending balance $ (160,499) $ (151,104) $ (160,499) $ (151,104)
Common Stock        
Increase (Decrease) in Stockholders' Equity        
Beginning balance (in shares) 13,319 4,792 6,962 4,792
Beginning balance $ 133 $ 48 $ 70 $ 48
Ending balance (in shares) 13,333 4,792 13,333 4,792
Ending balance $ 133 $ 48 $ 133 $ 48
Additional Paid-in Capital        
Increase (Decrease) in Stockholders' Equity        
Beginning balance 846,046 708,952 779,645 708,027
Stock-based compensation 324 716 (205) 1,641
Ending balance 846,451 709,668 846,451 709,668
Accumulated Deficit        
Increase (Decrease) in Stockholders' Equity        
Beginning balance (959,677) (847,278) (942,471) (827,380)
Net loss (46,456) (12,150) (63,662) (32,048)
Ending balance (1,006,133) (859,428) (1,006,133) (859,428)
Accumulated Other Comprehensive Loss        
Increase (Decrease) in Stockholders' Equity        
Beginning balance (888) (2,051) (1,610) (2,193)
Foreign currency translation adjustments, net (62) 659 660 801
Ending balance $ (950) $ (1,392) $ (950) $ (1,392)